| Date | Title | Description |
| 18.09.2024 | Implantica announces excellent data from an independent study of 158 RefluxStop™ patients from two centers in Germany – presented at the AUGIS meeting in UK | Implantica announces excellent data from an independent study of 158 RefluxStop™ patients from two centers in Germany – presented at the AUGIS meeting in UK
Wed, Sep 18, 2024 08:30 CET Report this content
Implantica AG (publ.), a medtech co... |
| 11.09.2024 | Implantica mourns the death of board member Prof. Dr. Klaus Neftel | Implantica mourns the death of board member Prof. Dr. Klaus Neftel
Wed, Sep 11, 2024 15:30 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces with re... |
| 21.08.2024 | New Frontiers in Medical Technology: RefluxStop™ and Type 1 Diabetes Awareness | In the ever-evolving landscape of medical technology, two recent developments stand out: the promising results of the RefluxStop™ device and the launch of the "Detect So You Can Decide" campaign by Breakthrough T1D. Both initiativ... |
| 21.08.2024 | Implantica publishes Interim Report January – June 2024 (Q2) | Implantica publishes Interim Report January – June 2024 (Q2)
Wed, Aug 21, 2024 08:00 CET Report this content
RefluxStop™ is on a wave of success – carried by a multitude of published studies with excellent outcomes from leading European Ref... |
| 20.08.2024 | Implantica announces RefluxStop™ pivotal 4-year study results published in the prestigious journal Surgical Endoscopy | Implantica announces RefluxStop™ pivotal 4-year study results published in the prestigious journal Surgical Endoscopy
Tue, Aug 20, 2024 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of introducing a... |
| 15.08.2024 | Implantica: Pioneering a New Era in GERD Treatment | In the world of medical technology, innovation is the lifeblood that keeps the industry vibrant. Implantica AG, a medtech company based in Switzerland, is at the forefront of this revolution. With its groundbreaking product, RefluxStop™, th... |
| 15.08.2024 | Implantica announces another landmark real-world RefluxStop™ study demonstrating excellent outcomes published in a prestigious top-tier journal | Implantica announces another landmark real-world RefluxStop™ study demonstrating excellent outcomes published in a prestigious top-tier journal
Thu, Aug 15, 2024 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the ... |
| 14.08.2024 | Implantica presents the second quarter 2024 on August 21 at 15:00 CEST | Implantica presents the second quarter 2024 on August 21 at 15:00 CEST
Wed, Aug 14, 2024 13:25 CET Report this content
Implantica AG (publ) invites investors to a presentation of the second quarter 2024 at 15:00 CEST on August 21. The inter... |
| 30.07.2024 | A New Dawn for GERD Treatment: Implantica's RefluxStop™ Breakthrough | In the world of medical technology, innovation is the lifeblood that fuels progress. Implantica AG, a medtech company, is at the forefront of this revolution with its groundbreaking device, RefluxStop™. This innovative solution aims to tack... |
| 30.07.2024 | Implantica announces excellent RefluxStop™ investigator initiated study results published in Scientific Reports, a Nature journal | Implantica announces excellent RefluxStop™ investigator initiated study results published in Scientific Reports, a Nature journal
Tue, Jul 30, 2024 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of i... |
| 25.07.2024 | Implantica announces continuing progress in modular PMA application to FDA for RefluxStop™ | Implantica announces continuing progress in modular PMA application to FDA for RefluxStop™
Thu, Jul 25, 2024 08:30 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the... |
| 18.07.2024 | Implantica launches RefluxStop™ advanced education program in Spain | Implantica launches RefluxStop™ advanced education program in Spain
Thu, Jul 18, 2024 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, brings together ... |
| 11.07.2024 | Implantica announces new health-economics data publication showing RefluxStop™’s superior cost-effectiveness for the Swiss healthcare system | Implantica announces new health-economics data publication showing RefluxStop™’s superior cost-effectiveness for the Swiss healthcare system
Thu, Jul 11, 2024 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the for... |
| 19.06.2024 | Implantica announces further expansion of RefluxStop™ access in the UK NHS public Hospital Network | Implantica announces further expansion of RefluxStop™ access in the UK NHS public Hospital Network
Wed, Jun 19, 2024 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology ... |
| 22.05.2024 | Bulletin from the Annual General Meeting of Implantica AG | Bulletin from the Annual General Meeting of Implantica AG
Wed, May 22, 2024 20:00 CET Report this content
Today, May 22, 2024, the annual general meeting (the “AGM”) of Implantica AG (publ) was held in Ruggel, Liechtenstein. The general mee... |
| 15.05.2024 | Implantica publishes Interim Report January – March 2024 (Q1) | Implantica publishes Interim Report January – March 2024 (Q1)
Wed, May 15, 2024 08:00 CET Report this content
RefluxStop™ on path to become standard of care for acid reflux treatment
Significant events in the first quarter of 2024
Submitted... |
| 14.05.2024 | Implantica announces the eighth RefluxStop™ center of excellence in Italy | Implantica announces the eighth RefluxStop™ center of excellence in Italy
Tue, May 14, 2024 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, welcomes a ne... |
| 08.05.2024 | Implantica presents the first quarter 2024 on May 15 at 15:00 CEST | Implantica presents the first quarter 2024 on May 15 at 15:00 CEST
Wed, May 08, 2024 14:30 CET Report this content
Implantica AG (publ) invites investors to a presentation of the first quarter 2024 at 15:00 CEST on May 15. The interim repor... |
| 02.05.2024 | Implantica’s RefluxStop™ is now available in seven hospitals in Spain adding two new centers of excellence | Implantica’s RefluxStop™ is now available in seven hospitals in Spain adding two new centers of excellence
Thu, May 02, 2024 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of bringing advanced techno... |
| 01.05.2024 | Notice of Annual General Meeting of Implantica AG | Notice of Annual General Meeting of Implantica AG
Wed, May 01, 2024 10:15 CET Report this content
The depository receipt holders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby invited to attend the annual general meeting to be hel... |
| 30.04.2024 | Implantica Announces Real-World Clinical Data from over 200 Patients treated across five RefluxStop™ Centers in Europe Presented at SAGES in Cleveland | Implantica Announces Real-World Clinical Data from over 200 Patients treated across five RefluxStop™ Centers in Europe Presented at SAGES in Cleveland
Tue, Apr 30, 2024 08:00 CET Report this content
Implantica AG (publ.), a medtech company ... |
| 26.04.2024 | Implantica publishes Annual Report 2023 | Implantica publishes Annual Report 2023
Fri, Apr 26, 2024 08:30 CET Report this content
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal ... |
| 27.03.2024 | Implantica submits U.S. FDA Premarket Approval (PMA) application for RefluxStop® (first module) | Implantica submits U.S. FDA Premarket Approval (PMA) application for RefluxStop® (first module)
Wed, Mar 27, 2024 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into t... |
| 26.03.2024 | Implantica completes Human Factors Validation Study for RefluxStop™ as part of the US FDA Premarket Approval Process | Implantica completes Human Factors Validation Study for RefluxStop™ as part of the US FDA Premarket Approval Process
Tue, Mar 26, 2024 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of bringing advan... |
| 19.03.2024 | Implantica wins another RefluxStop™ public tender in Europe, this time in Spain with Hospital Universitario de Getafe | Implantica wins another RefluxStop™ public tender in Europe, this time in Spain with Hospital Universitario de Getafe
Tue, Mar 19, 2024 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of bringing adva... |
| 05.03.2024 | Implantica announces another major public hospital purchase agreement win in Italy, further strengthening RefluxStop™’s broader acceptance in public healthcare systems in Europe | Implantica announces another major public hospital purchase agreement win in Italy, further strengthening RefluxStop™’s broader acceptance in public healthcare systems in Europe
Tue, Mar 05, 2024 08:00 CET Report this content
Implantica AG ... |
| 15.02.2024 | Implantica’s RefluxStop™ now available in Munich | Implantica’s RefluxStop™ now available in Munich
Thu, Feb 15, 2024 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces the first RefluxStop™ proced... |
| 13.02.2024 | Implantica announces first RefluxStop™ public tender win, paving the way for permanent reimbursement in Italy | Implantica announces first RefluxStop™ public tender win, paving the way for permanent reimbursement in Italy
Tue, Feb 13, 2024 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of bringing advanced tec... |
| 06.02.2024 | Implantica continues to expand in Germany with another reflux Center of Excellence in Berlin | Implantica continues to expand in Germany with another reflux Center of Excellence in Berlin
Tue, Feb 06, 2024 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the ... |
| 05.02.2024 | Implantica presents the fourth quarter 2023 on February 16 at 15:00 CET | Implantica presents the fourth quarter 2023 on February 16 at 15:00 CET
Mon, Feb 05, 2024 09:00 CET Report this content
Implantica AG (publ) invites investors to a presentation of the fourth quarter 2023 at 15:00 CET on February 16. The int... |
| 01.02.2024 | Implantica's RefluxStop™ featured in seven presentations accepted at the largest US GI conference, SAGES | Implantica's RefluxStop™ featured in seven presentations accepted at the largest US GI conference, SAGES
Thu, Feb 01, 2024 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technolo... |
| 30.01.2024 | Implantica’s RefluxStop™ procedure now available in Norway | Implantica’s RefluxStop™ procedure now available in Norway
Tue, Jan 30, 2024 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that the RefluxSto... |
| 18.12.2023 | Implantica adds another RefluxStop™ center in Spain | Implantica adds another RefluxStop™ center in Spain
Mon, Dec 18, 2023 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces another key public hospit... |
| 05.12.2023 | Implantica announces live surgery with RefluxStop™ attended by nearly 2’000 surgeons and streamed by up to 100’000 online | Implantica announces live surgery with RefluxStop™ attended by nearly 2’000 surgeons and streamed by up to 100’000 online
Tue, Dec 05, 2023 08:00 CET Report this content
Implantica AG (publ), a medtech company at the forefront of bringing a... |
| 21.11.2023 | Implantica's RefluxStop[TM], a promising new procedure for chronic acid reflux, offered for the first time in the NHS in UK | Implantica's RefluxStop[TM], a promising new procedure for chronic acid reflux, offered for the first time in the NHS in UK
Tue, Nov 21, 2023 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of bringin... |
| 17.11.2023 | Implantica presents the third quarter 2023 on November 22 at 15:00 CET | Implantica presents the third quarter 2023 on November 22 at 15:00 CET
Fri, Nov 17, 2023 08:00 CET Report this content
Implantica AG (publ) invites investors to a presentation of the third quarter 2023 at 15:00 CET on November 22. The inter... |
| 16.11.2023 | Implantica’s RefluxStop[TM] health economic research, showing superior cost-effectiveness, has received top-recognition at ISPOR, the world’s leading European Health-Economics Conference | Implantica’s RefluxStop[TM] health economic research, showing superior cost-effectiveness, has received top-recognition at ISPOR, the world’s leading European Health-Economics Conference
Thu, Nov 16, 2023 08:00 CET Report this content
Impla... |
| 15.11.2023 | Implantica’s RefluxStop™ makes an impact at the leading Annual European Foregut Society Meeting | Implantica’s RefluxStop™ makes an impact at the leading Annual European Foregut Society Meeting
Wed, Nov 15, 2023 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into t... |
| 14.11.2023 | Implantica takes a big step forward at its 2[nd] Annual RefluxStop™ Users Meeting | Implantica takes a big step forward at its 2[nd] Annual RefluxStop™ Users Meeting
Tue, Nov 14, 2023 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, annou... |
| 10.10.2023 | Implantica’s RefluxStop ™[ ]made a substantial impact at the American Foregut Society (AFS) | Implantica’s RefluxStop ™[ ]made a substantial impact at the American Foregut Society (AFS)
Tue, Oct 10, 2023 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the b... |
| 19.09.2023 | Implantica announces two independent scientific presentations on RefluxStop™ from the 2023 Annual ISDE conference | Implantica announces two independent scientific presentations on RefluxStop™ from the 2023 Annual ISDE conference
Tue, Sep 19, 2023 08:00 CET Report this content
Implantica AG (publ.), a medtech company at the forefront of bringing advanced... |
| 12.09.2023 | Invitation to Implantica’s CMD in Stockholm on September 26, 2023 | Invitation to Implantica’s CMD in Stockholm on September 26, 2023
Tue, Sep 12, 2023 08:00 CET Report this content
Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, invites investors, ana... |
| 07.09.2023 | Implantica receives MDR certification for RefluxStop™ | Implantica receives MDR certification for RefluxStop™
Thu, Sep 07, 2023 08:00 CET Report this content
Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, is proud to announce that it has r... |
| 21.08.2023 | Save the date: Implantica Capital Markets Day 2023 | Save the date: Implantica Capital Markets Day 2023
Mon, Aug 21, 2023 08:00 CET Report this content
Implantica AG (publ) will arrange a Capital Markets Day (CMD) for investors, analysts and media on Tuesday, 26 September 2023, starting at 14... |
| 18.08.2023 | Implantica presents the second quarter 2023 on August 24 at 15:00 CET | Implantica presents the second quarter 2023 on August 24 at 15:00 CET
Fri, Aug 18, 2023 08:00 CET Report this content
Implantica AG (publ) invites investors to a presentation of the second quarter 2023 at 15:00 CET on August 24. The interim... |
| 29.06.2023 | Implantica Further Expands its Commercial Footprint in Italy | Implantica Further Expands its Commercial Footprint in Italy
Thu, Jun 29, 2023 08:00 CET Report this content
Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that the first Re... |
| 15.06.2023 | Implantica reports that two independent surgeons presented their RefluxStop™ patient data at the 2023 Annual Swiss College of Surgeons Congress (SCS) | Implantica reports that two independent surgeons presented their RefluxStop™ patient data at the 2023 Annual Swiss College of Surgeons Congress (SCS)
Thu, Jun 15, 2023 09:10 CET Report this content
Implantica AG (publ), a medtech company at... |
| 08.06.2023 | Implantica Announces Completion of First RefluxStop™ procedures by the President of the European Foregut Society | Implantica Announces Completion of First RefluxStop™ procedures by the President of the European Foregut Society
Thu, Jun 08, 2023 08:00 CET Report this content
Implantica AG (publ), a medtech company at the forefront of bringing advanced t... |
| 30.05.2023 | Implantica’s RefluxStop™ Wins Medtop Tech’s Most Innovative Device Category Award | Implantica’s RefluxStop™ Wins Medtop Tech’s Most Innovative Device Category Award
Tue, May 30, 2023 08:00 CET Report this content
Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announ... |
| 25.05.2023 | Bulletin from the Annual General Meeting of Implantica AG | Bulletin from the Annual General Meeting of Implantica AG
Thu, May 25, 2023 20:45 CET Report this content
Today, May 25, 2023, the annual general meeting (the “AGM”) of Implantica AG (publ) was held in Ruggel, Liechtenstein. The general mee... |
| 16.05.2023 | Implantica announces that RefluxStop™ results were presented at the DDW Conference in Chicago | Implantica announces that RefluxStop™ results were presented at the DDW Conference in Chicago
Tue, May 16, 2023 08:00 CET Report this content
Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the ... |
| 09.05.2023 | Implantica recognized among the “50 Admired Companies to Watch in 2023” | Implantica recognized among the “50 Admired Companies to Watch in 2023”
Tue, May 09, 2023 08:00 CET Report this content
Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces today ... |
| 05.05.2023 | Implantica presents the first quarter 2023 on May 12 at 15:00 CET | Implantica presents the first quarter 2023 on May 12 at 15:00 CET
Fri, May 05, 2023 13:30 CET Report this content
Implantica AG (publ) invites investors to a presentation of the first quarter 2023 at 15:00 CET on May 12. The interim report ... |
| 04.05.2023 | Notice of Annual General Meeting of Implantica AG | Notice of Annual General Meeting of Implantica AG
Thu, May 04, 2023 22:45 CET Report this content
The depository receipt holders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby invited to attend the annual general meeting to be hel... |
| 02.05.2023 | Implantica Announces 100[th] RefluxStop™ Procedure Completed in a Single Center of Excellence in Germany | Implantica Announces 100[th] RefluxStop™ Procedure Completed in a Single Center of Excellence in Germany
Tue, May 02, 2023 08:00 CET Report this content
Implantica AG (publ), a medtech company at the forefront of bringing advanced technolog... |
| 20.04.2023 | Implantica publishes Annual Report 2022 | Implantica publishes Annual Report 2022
Thu, Apr 20, 2023 08:30 CET Report this content
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal ... |
| 15.04.2023 | Repurchase of Implantica AG own shares during week 15, 2023 | Repurchase of Implantica AG own shares during week 15, 2023
Sat, Apr 15, 2023 00:01 CET Report this content
Implantica AG (publ) has during week 15 completed repurchases of own shares (Swedish Depository Receipts representing class A shares... |
| 06.04.2023 | Implantica Announces Another Major European Center of Excellence in Italy starting with the RefluxStop™ procedure | Implantica Announces Another Major European Center of Excellence in Italy starting with the RefluxStop™ procedure
Thu, Apr 06, 2023 07:30 CET Report this content
Implantica AG (publ), a medtech company at the forefront of bringing advanced ... |
| 06.04.2023 | Repurchase of Implantica AG own shares until April 6, 2023 | Repurchase of Implantica AG own shares until April 6, 2023
Thu, Apr 06, 2023 19:31 CET Report this content
Implantica AG (publ) has from 29 March 2023 until 6 April 2023 completed repurchases of own shares (Swedish Depository Receipts repre... |
| 03.04.2023 | Implantica announces Dr. med. Yves Borbély Presented his 3-year Data on RefluxStop[TM] []at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) | Implantica announces Dr. med. Yves Borbély Presented his 3-year Data on RefluxStop[TM] []at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)
Mon, Apr 03, 2023 08:30 CET Report this content
Implantica AG (publ), a med... |
| 30.03.2023 | Implantica Launches RefluxStop™ in Italy | Implantica Launches RefluxStop™ in Italy
Thu, Mar 30, 2023 08:30 CET Report this content
Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces today that the first RefluxStop™ proc... |
| 29.03.2023 | Implantica presents at Redeye Future of Healthcare Seminar | Implantica presents at Redeye Future of Healthcare Seminar
Wed, Mar 29, 2023 08:30 CET Report this content
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, announces that on Thursday, ... |
| 22.03.2023 | Implantica to repurchase own shares | Implantica to repurchase own shares
Wed, Mar 22, 2023 08:30 CET Report this content
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, announces that the Board of Directors has decided t... |
| 06.03.2023 | Implantica Announces RefluxStop Launch in Spain | Implantica Announces RefluxStop Launch in Spain
Mon, Mar 06, 2023 08:30 CET Report this content
Implantica AG (publ), a MedTech company at the forefront of bringing advanced technology into the body, announces today that the first two Reflu... |
| 16.02.2023 | Implantica announces RefluxStop™ launch in Scandinavia | Implantica announces RefluxStop™ launch in Scandinavia
Thu, Feb 16, 2023 08:30 CET Report this content
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, announces that RefluxStop is bei... |
| 13.02.2023 | Implantica presents the fourth quarter 2022 on February 17 at 15:00 CET | Implantica presents the fourth quarter 2022 on February 17 at 15:00 CET
Mon, Feb 13, 2023 09:30 CET Report this content
Implantica AG (publ) invites investors to a presentation of the fourth quarter 2022 at 15:00 CET on February 17. The int... |
| 25.01.2023 | Implantica has successfully completed ISO 13485 and MDSAP recertifications | Implantica has successfully completed ISO 13485 and MDSAP recertifications
Wed, Jan 25, 2023 08:30 CET Report this content
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, announces th... |
| 14.11.2022 | Implantica Receives GHP’s 2022 Most Innovative MedTech Company Award – Central Europe | Implantica Receives GHP’s 2022 Most Innovative MedTech Company Award – Central Europe
Mon, Nov 14, 2022 10:40 CET Report this content
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, a... |
| 10.11.2022 | Implantica Presents RefluxStop’s Health Economic Impact at ISPOR Europe 2022 | Implantica Presents RefluxStop’s Health Economic Impact at ISPOR Europe 2022
Thu, Nov 10, 2022 08:30 CET Report this content
Implantica AG (publ.), a MedTech company at the forefront of bringing advanced technology into the body, attended t... |
| 09.11.2022 | Implantica presents the third quarter 2022 on November 15 at 15:00 CET | Implantica presents the third quarter 2022 on November 15 at 15:00 CET
Wed, Nov 09, 2022 15:30 CET Report this content
Implantica AG (publ) invites investors to a presentation of the third quarter 2022 at 15:00 CET on November 15. The inter... |
| 07.11.2022 | Implantica’s innovative RefluxStop ™ Treatment Solution showcased at the annual European Foregut Society (EFS) meeting | Implantica’s innovative RefluxStop ™ Treatment Solution showcased at the annual European Foregut Society (EFS) meeting
Mon, Nov 07, 2022 08:30 CET Report this content
Implantica AG (publ.), a MedTech company at the forefront of bringing adv... |
| 23.08.2022 | Implantica publishes Interim Report Q2 2022 | Implantica publishes Interim Report Q2 2022
Tue, Aug 23, 2022 08:00 CET Report this content
Executing on RefluxStop™ Commercialisation Strategy
Significant events in the second quarter of 2022 Implantica has completed the first AppetiteCont... |
| 22.08.2022 | Implantica presents a robust health economic analysis of RefluxStop™ conducted by University of York, UK | Implantica presents a robust health economic analysis of RefluxStop™ conducted by University of York, UK
Mon, Aug 22, 2022 08:30 CET Report this content
Implantica AG (publ), a MedTech company at the forefront of the upcoming eHealth revolu... |
| 17.08.2022 | Implantica presents the second quarter 2022 on August 23 at 15:00 CEST | Implantica presents the second quarter 2022 on August 23 at 15:00 CEST
Wed, Aug 17, 2022 13:00 CET Report this content
Implantica AG (publ) invites investors to a presentation of the second quarter 2022 at 15:00 CEST on August 23. The inter... |
| 18.07.2022 | Implantica engages Pareto Securities as liquidity provider | Implantica engages Pareto Securities as liquidity provider
Mon, Jul 18, 2022 10:29 CET Report this content
Implantica AG (publ), a med-tech company at the forefront of the upcoming eHealth revolution, engages Pareto Securities as liquidity ... |
| 16.06.2022 | Implantica Applauded by Frost & Sullivan for Transforming Gastroesophageal Reflux Disease Treatment with Its Revolutionary Implant RefluxStop™ | The RefluxStop™ device prevents the regurgitation of stomach fluid into the esophagus and addresses the limitations of proton pump inhibitors (PPIs) and existing surgical methods and devices for treating acid reflux disease.
SAN ANTONIO, Ju... |
| 16.06.2022 | Implantica receives Frost & Sullivan’s 2022 European Technology Innovation Leadership Award for RefluxStop™ – an Innovative Treatment Solution for Acid Reflux | Implantica receives Frost & Sullivan’s 2022 European Technology Innovation Leadership Award for RefluxStop™ – an Innovative Treatment Solution for Acid Reflux
Thu, Jun 16, 2022 08:30 CET Report this content
Implantica AG (publ), a med-t... |
| 11.05.2022 | Implantica publishes Interim Report Q1, January – March 2022 | Implantica publishes Interim Report Q1, January – March 2022
Wed, May 11, 2022 08:00 CET Report this content
SUCCESSFUL REFLUXSTOP™ MARKET ACCESS STRATEGY
Implantica publishes Interim Report Q1, January – March 2022
SUCCESSFUL REFLUXSTOP™ M... |
| 10.05.2022 | Bulletin from the Annual General Meeting in Implantica AG | Bulletin from the Annual General Meeting in Implantica AG
Tue, May 10, 2022 16:00 CET Report this content
Today, May 10, 2022, the annual general meeting (the “AGM”) of Implantica AG (publ) was held in Vaduz. The general meeting resolved to... |
| 05.05.2022 | Implantica presents the first quarter 2022 on May 11 at 15:00 CEST | Implantica presents the first quarter 2022 on May 11 at 15:00 CEST
Thu, May 05, 2022 13:00 CET Report this content
Implantica AG (publ) invites investors to a presentation of the first quarter 2022 at 15:00 CEST on May 11. The interim repor... |
| 21.04.2022 | Notice of Annual General Meeting of Implantica AG | Notice of Annual General Meeting of Implantica AG
Thu, Apr 21, 2022 08:30 CET Report this content
The shareholders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby given notice of the annual general meeting on Tuesday, May 10, 2022,... |
| 06.04.2022 | Implantica publishes Annual Report 2021 | Implantica publishes Annual Report 2021
Wed, Apr 06, 2022 08:30 CET Report this content
Implantica AG (publ), an emerging med-tech company providing novel medical implants for unmet medical needs, is publishing its annual report for the fis... |
| 14.03.2022 | Implantica presents at Aktiedagen Stockholm on March 15 at 18:30 | Implantica presents at Aktiedagen Stockholm on March 15 at 18:30
Mon, Mar 14, 2022 08:30 CET Report this content
Implantica AG (publ), a med-tech company providing smart medical implants using advanced eHealth technology at the forefront of... |
| 07.03.2022 | Implantica announces launch of RefluxStop™ in UK | Implantica announces launch of RefluxStop™ in UK
Mon, Mar 07, 2022 08:00 CET Report this content
Implantica AG (publ), a med-tech company providing smart medical implants using advanced eHealth technology at the forefront of the upcoming eH... |
| 21.02.2022 | Implantica announces filing of comprehensive eHealth patent applications for its platform technology | Implantica announces filing of comprehensive eHealth patent applications for its platform technology
Mon, Feb 21, 2022 08:00 CET Report this content
Implantica AG (publ), an emerging and fast growing med-tech company that is pioneering inno... |
| 18.02.2022 | Implantica publishes Year-end Report, January – December 2021 | Implantica publishes Year-end Report, January – December 2021
Fri, Feb 18, 2022 08:00 CET Report this content
GREAT PROGRESS IN U.S. APPROVAL
Significant events in the fourth quarter of 2021 The U.S. approval has taken a giant leap forward ... |
| 14.02.2022 | Implantica presents the fourth quarter 2021 on February 18 at 15:00 CET | Implantica presents the fourth quarter 2021 on February 18 at 15:00 CET
Mon, Feb 14, 2022 08:30 CET Report this content
Implantica AG (publ) invites investors to a presentation of the fourth quarter 2021 at 15:00 CET on February 18. The int... |
| 11.02.2022 | Implantica conducts innovative eHealth workshop | Implantica conducts innovative eHealth workshop
Fri, Feb 11, 2022 08:30 CET Report this content
Implantica AG (publ), an emerging and fast growing med-tech company that is pioneering innovative solutions to treat chronic health conditions w... |
| 01.02.2022 | Implantica Taps Former Medtronic Executive Paul Mead for COO Role | Implantica Taps Former Medtronic Executive Paul Mead for COO Role
Tue, Feb 01, 2022 08:00 CET Report this content
Implantica AG (publ), an emerging and fast growing med-tech company that is pioneering innovative solutions to treat chronic h... |
| 10.01.2022 | Implantica to present at Digital Medicine & Medtech Showcase 2022 | Implantica to present at Digital Medicine & Medtech Showcase 2022 Mon, Jan 10, 2022 08:30 CET
Implantica AG (publ) announces today that its founder and CEO, Peter Forsell, is presenting, Implantica – the future of eHealth, in an online ... |
| 14.12.2021 | Implantica successfully performs cadaver implantations of pipeline products and several related tests at the cadaver lab | Implantica successfully performs cadaver implantations of pipeline products and several related tests at the cadaver lab Tue, Dec 14, 2021 08:30 CET
Implantica AG (publ) announces today advances in development of its pipeline products at a ... |
| 24.11.2021 | Implantica publishes Interim Report Q3, January – September 2021 | Implantica publishes Interim Report Q3, January – September 2021 Wed, Nov 24, 2021 08:00 CET
A BIG STEP FORWARD WITH FDA IN U.S.
Significant events in the third quarter of 2021 Implantica incorporated wholly owned subsidiary in the US, Impl... |
| 22.11.2021 | Implantica expands executive team with new Chief Market Access & Strategy Officer | Implantica expands executive team with new Chief Market Access & Strategy Officer Mon, Nov 22, 2021 08:30 CET
Implantica AG (publ) announces today the addition of Amit Kukreja in the position of Chief Market Access & Strategy Office... |
| 18.11.2021 | Implantica presents the third quarter 2021 on November 24 at 15:00 CET | Implantica presents the third quarter 2021 on November 24 at 15:00 CET Thu, Nov 18, 2021 08:00 CET
Implantica AG (publ) invites investors to a presentation of the third quarter 2021 at 15:00 CET on November 24. The interim report for the th... |
| 08.11.2021 | Implantica takes a big step forward in its RefluxStop™ U.S. approval process discussions with FDA | Implantica takes a big step forward in its RefluxStop™ U.S. approval process discussions with FDA Mon, Nov 08, 2021 08:30 CET
Implantica AG (publ) today announces feedback from its third pre-submission meeting with the U.S. Food and Drug Ad... |
| 15.10.2021 | Implantica announces initial UK surgical training for RefluxStop™ | Implantica announces initial UK surgical training for RefluxStop™ Fri, Oct 15, 2021 08:30 CET
Implantica AG (publ) today announces that surgeons from three prominent reflux centers in the UK have completed RefluxStop™ training.
“We are plea... |
| 17.09.2021 | Bulletin from the Extraordinary General Meeting in Implantica AG – assets of EUR 117 million have been contributed to Implantica without monetary or share compensation | Bulletin from the Extraordinary General Meeting in Implantica AG – assets of EUR 117 million have been contributed to Implantica without monetary or share compensation Fri, Sep 17, 2021 16:55 CET
Today, September 17, 2021, the extraordinary... |
| 24.08.2021 | Implantica publishes Interim Report Q2, January-June 2021 | Implantica publishes Interim Report Q2, January-June 2021 Tue, Aug 24, 2021 08:00 CET
“We are very enthusiastic about the integration of the eHealth platform in our AppetiteControl™ device and this ground-breaking work fills the whole team ... |
| 17.08.2021 | Resubmission: Implantica announces contribution of assets of EUR 117 million by the main shareholder to the capital reserves | Resubmission: Implantica announces contribution of assets of EUR 117 million by the main shareholder to the capital reserves Tue, Aug 17, 2021 22:47 CET
The resubmission relates to the reference that the Market Abuse Regulation has been add... |
| 17.08.2021 | Implantica announces contribution of assets of EUR 117 million by the main shareholder to the capital reserves | Implantica announces contribution of assets of EUR 117 million by the main shareholder to the capital reserves Tue, Aug 17, 2021 17:23 CET
Implantica AG (publ) today announces that it will accept a contribution of EUR 117 million of assets ... |
